These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16364702)

  • 1. Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas.
    Di Stefano G; Busi C; Fiume L; Chieco P; Pariali M
    Dig Liver Dis; 2006 Apr; 38(4):284-5. PubMed ID: 16364702
    [No Abstract]   [Full Text] [Related]  

  • 2. A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade.
    Di Stefano G; Fiume L; Baglioni M; Bolondi L; Busi C; Chieco P; Kratz F; Manaresi F; Pariali M
    Liver Int; 2006 Aug; 26(6):726-33. PubMed ID: 16842330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis.
    Di Stefano G; Fiume L; Domenicali M; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Pariali M; Bernardi M
    Dig Liver Dis; 2006 Jun; 38(6):404-8. PubMed ID: 16595196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug.
    Fiume L; Baglioni M; Bolondi L; Farina C; Di Stefano G
    Drug Discov Today; 2008 Nov; 13(21-22):1002-9. PubMed ID: 18755287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging.
    Di Stefano G; Fiume L; Baglioni M; Bolondi L; Chieco P; Kratz F; Pariali M; Rubini G
    Dig Liver Dis; 2008 Apr; 40(4):278-84. PubMed ID: 18054847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties.
    Baglioni M; Fiume L; Bolondi L; Farina C; Kratz F; Di Stefano G
    Dig Liver Dis; 2008 Dec; 40(12):963-4. PubMed ID: 18606580
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors.
    Di Stefano G; Fiume L; Bolondi L; Lanza M; Pariali M; Chieco P
    Liver Int; 2005 Aug; 25(4):854-60. PubMed ID: 15998437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
    Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
    Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fibrous capsule formation on doxorubicin distribution in radiofrequency ablated rat livers.
    Blanco E; Qian F; Weinberg B; Stowe N; Anderson JM; Gao J
    J Biomed Mater Res A; 2004 Jun; 69(3):398-406. PubMed ID: 15127386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
    Fiume L; Bolondi L; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Di Stefano G
    J Hepatol; 2005 Oct; 43(4):645-52. PubMed ID: 16023760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier.
    Di Stefano G; Kratz F; Lanza M; Fiume L
    Dig Liver Dis; 2003 Jun; 35(6):428-33. PubMed ID: 12868680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A surface-adaptive nanocarrier to prolong circulation time and enhance cellular uptake.
    Cheng T; Ma R; Zhang Y; Ding Y; Liu J; Ou H; An Y; Liu J; Shi L
    Chem Commun (Camb); 2015 Oct; 51(81):14985-8. PubMed ID: 26307207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats.
    Di Stefano G; Fiume L; Baglioni M; Busi C; Bolondi L; Farina C; Mori F; Chieco P; Pariali M; Kratz F; Molin L; Salmaso S; Caliceti P
    Eur J Pharm Sci; 2008 Feb; 33(2):191-8. PubMed ID: 18201877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
    Xu XY; Zhou JP; Li L; Zhang Y; Huo MR; Wang X; Lü L
    Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model.
    Cochran MC; Eisenbrey JR; Soulen MC; Schultz SM; Ouma RO; White SB; Furth EE; Wheatley MA
    Acad Radiol; 2011 Nov; 18(11):1341-8. PubMed ID: 21971256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of liposomal forms of cytostatics].
    Dranov AL; Dudnichenko AS; Mezin IA; Menzeleev RF; Krasnopol'skiĭ IuM; Shvets VI
    Biull Eksp Biol Med; 1996 Jan; 121(1):85-8. PubMed ID: 8680014
    [No Abstract]   [Full Text] [Related]  

  • 17. Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas.
    Di Stefano G; Busi C; Derenzini M; Trerè D; Fiume L
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):173-7. PubMed ID: 9675653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour cell uptake of lactosaminated and intact N-succinyl-chitosans and antitumour effects of conjugates with mitomycin C.
    Kato Y; Onishi H; Machida Y
    Anticancer Res; 2002; 22(5):2771-6. PubMed ID: 12529995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of the EPC and HEPC sterically stabilized doxorubicin liposomes and further studies on pharmacokinetics in rats].
    Yu M; Wang Y; Shu G; Zhu Z; Fang S; Wang L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):597-9. PubMed ID: 18693438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
    Zara GP; Cavalli R; Fundarò A; Bargoni A; Caputo O; Gasco MR
    Pharmacol Res; 1999 Sep; 40(3):281-6. PubMed ID: 10479474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.